Login| Sign Up| Help| Contact|

Patent Searching and Data


Title:
NOVEL ANTI-TIM-3 ANTIBODIES
Document Type and Number:
WIPO Patent Application WO/2019/179420
Kind Code:
A1
Abstract:
The present disclosure provides anti-TIM-3 antibodies or antigen-binding fragments thereof, isolated polynucleotides encoding the same, pharmaceutical compositions comprising the same, and the uses thereof.

More Like This:
JP3759226RETROVIRUS OF HIV GROUP AND ITS USE
WO/2000/018428HEDGEHOG AND PATCHED ANTAGONISTS FOR INHIBITING CELL AND TISSUE GROWTH AND DIFFERENTIATION AND USES THEREFOR
JP2980986[Title of Invention] Tumor-killing T lymphocytes
Inventors:
NIE SIWEI (CN)
ZHENG YONG (CN)
LI JING (CN)
Application Number:
PCT/CN2019/078661
Publication Date:
September 26, 2019
Filing Date:
March 19, 2019
Export Citation:
Click for automatic bibliography generation   Help
Assignee:
WUXI BIOLOGICS SHANGHAI CO LTD (CN)
WUXI BIOLOGICS IRELAND LTD (IE)
International Classes:
A61K39/00; C07K16/28; A61P35/00
Domestic Patent References:
WO2018036561A12018-03-01
WO2018013818A22018-01-18
WO2017205721A12017-11-30
WO2017031242A12017-02-23
Foreign References:
TW201736397A2017-10-16
US20170190777A12017-07-06
CN103079644A2013-05-01
Other References:
SHIN FN ET AL.: "Prospects for TIM3-Targeted Antitumor Immunotherapy", CANCER RESEARCH, vol. 71, no. 21, 18 October 2011 (2011-10-18), pages 6567 - 6571, XP002741957, doi:10.1158/0008-5472.CAN-11-1487
See also references of EP 3768725A4
Attorney, Agent or Firm:
JUN HE LAW OFFICES (CN)
Download PDF:
View/Download PDF      PDF Help



 
Previous Patent: BATTERY DEVICE AND ELECTRONIC CIGARETTE

Next Patent: NOVEL BISPECIFIC PD-1/CTLA-4 ANTIBODY MOLECULES